Who are AZD5004's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): BION-1301, BAY3723113, TAK-771.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/azd5004.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

AZD5004 — Competitive Intelligence Brief

AZD5004 (AZD5004) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: FGFR4 inhibitor. Area: Oncology.

phase 2 FGFR4 inhibitor FGFR4 Oncology Small molecule Live · refreshed every 30 min

Target snapshot

AZD5004 (AZD5004) — AstraZeneca. AZD5004 is a selective inhibitor of fibroblast growth factor receptor 4 (FGFR4) that blocks aberrant FGF signaling in hepatocellular carcinoma and other cancers.

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
AZD5004 TARGET	AZD5004	AstraZeneca	phase 2	FGFR4 inhibitor	FGFR4
BION-1301	BION-1301	Chinook Therapeutics, Inc.	phase 3	FGFR4 inhibitor monoclonal antibody	FGFR4 (Fibroblast Growth Factor Receptor 4)
BAY3723113	BAY3723113	Bayer	phase 3	FGFR4 kinase inhibitor	FGFR4
TAK-771	TAK-771	Takeda	phase 3	FGFR4 selective inhibitor	FGFR4 (Fibroblast Growth Factor Receptor 4)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (FGFR4 inhibitor class)

AstraZeneca · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). AZD5004 — Competitive Intelligence Brief. https://druglandscape.com/ci/azd5004. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab